MPM Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 27

Professionals
  • Investments
  • 384

  • Portfolio
  • 34

  • Exits
  • 228

Exits

MPM Capital General Information

Description

Founded in 1997, MPM Capital is a venture capital firm based in Cambridge, Massachusetts. The firm prefers to invest in seed-stage, early-stage, later-stage, and growth-stage companies. The firm prefers to invest in the biotechnology, healthcare, and life sciences sectors in the United States.

Contact Information

Formerly Known As
MPM Asset Management
Year Founded
1997
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
  • 450 Kendall Street
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

MPM Capital Investments & Acquisitions (384)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cardiac Dimensions 22-Dec-2022 Later Stage VC 0000 Therapeutic Devices Generating Revenue/Not Profitable
000000000 (0000 00 13-Dec-2022 00000 00000 0000 Drug Discovery Startup 0000000 00000 00.0
000000 08-Sep-2022 00000 00000 0000 Drug Discovery Generating Revenue 000000 00000000 00
00000 00000000 18-Aug-2022 00000 00000 0000 Drug Discovery Pre-Clinical Trials 0000000 00000 00.0
0000 000000000000 16-Aug-2022 00000 00000 00000 Drug Delivery Product Development 0000000 0000000 00
000000 00000000000 29-Jun-2022 00000 00000 00000 Drug Delivery Generating Revenue
0000 0000000000000 02-Dec-2021 00000 00000 0000 Drug Discovery Out of Business 0000 00000
00000 000000000000 08-Nov-2021 0000 0000 Drug Discovery Generating Revenue 0000 00000 00.0
Protego Biopharma 19-Oct-2021 Later Stage VC 0000 Drug Discovery Generating Revenue 000000 0000000
Burrage Capital Management 08-Jul-2021 Merger/Acquisition Private Equity Generating Revenue 0000000 0000000 00
You’re viewing 10 of 384 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MPM Capital Exits (228)

Company Name Exit Date Exit Type Exit Size
Triplet Therapeutics 12-Oct-2022 Out of Business
000000 00000000000 01-Jun-2022 000000000000000000
0000000 0000000000 02-Nov-2021 000 00000
00000000 000000000 01-Oct-2021 000000000000000000 00000
000000 00000000000 30-Apr-2021 000 00 00000000
00000000 000000000 30-Apr-2021 000 00000
000000 00000000000 24-Feb-2021 000 00 00000000
0000000 12-Feb-2021 000000 0000000000 0000
Dyne Therapeutics 21-Jan-2021 Public Investment 2nd Offering 00000
TCR2 Therapeutics 21-Jan-2021 Public Investment 2nd Offering 00000
You’re viewing 10 of 228 exits. Get the full list »

MPM Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore MPM Capital‘s full profile, request access.

Request a free trial

MPM Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

MPM Capital Team (96)

Name Title Deals Funds Boards Office
Kristen Laguerre Managing Director, Chief Financial Officer & Chief Operating Officer 0 0 Cambridge, MA
Ansbert Gadicke MD Co-Founder & Managing Director 00 00 0 Cambridge, MA
Luke Evnin Ph.D Co-Founder & Managing Director 00 00 0 Brisbane, CA
Bard Geesaman Ph.D Managing Director 00 0 0 Cambridge, MA
David Stack Managing Director 0 0 0 Cambridge, MA
You’re viewing 5 of 96 team members. Get the full list »